Literature DB >> 24875087

Trial watch: Lung cancer trial aims to bolster personalized medicine.

Charlotte Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24875087     DOI： 10.1038/nrd4341

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  NCI-MATCH pairs tumor mutations with matching drugs.

Authors:  Vicki Brower
Journal:  Nat Biotechnol       Date:  2015-08       Impact factor: 54.908

Review 2.  The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research.

Authors:  Donald A Berry
Journal:  Mol Oncol       Date:  2015-03-11       Impact factor: 6.603
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.